Feed SEPN
SE
Septerna Inc SEPN · NASDAQ
$45.23 +2.21% (+$0.98)
Depth
- Market cap
- $2.07B
- Enterprise value
- $2.00B
- P/E
- -
- Forward P/E
- -
- PEG
- -
- P/S
- 20.9x
- P/FCF
- 19.7x
- EV/EBITDA
- -
- ROIC
- -9.4%
- Gross margin
- 99.6%
- Net margin
- -24.5%
- Dividend yield
- -
- Payout ratio
- -
- Net debt/EBITDA
- -
- Beta
- 2.28
- Free float
- 41.9%
Sector
Healthcare
Industry
Biotechnology
CEO
Jeffrey T. Finer
Employees
123
Headquarters
South San Francisco
Valuation
Is today's price reasonable?
Growth and estimates
Is it growing, and what comes next?
- What speaks for it: Analysts expect revenue to grow by 109% this fiscal year.
- What to watch: It missed profit estimates 5 times in the last 8 quarters.
Profitability and quality
How much of the revenue is left, and how well does the company use its capital?
- What speaks for it: Out of every 100 USD of revenue, 106 USD is left as free cash.
- What to watch: The company made a loss over the last 12 months.
Financial health
Can it carry its debt?
- What speaks for it: It holds more cash than debt: $84.7M against $22.5M.
- What to watch: It passes only 3 of the 9 points of the Piotroski financial health test.
Capital and dividends
What does the company do with the money it earns?
Analysts
What do the professionals think, and is it changing?
Owners and insiders
Who holds the stock, and what is management doing?
Segments
Which part of the company is growing?
Peer comparison
How does it compare with similar companies?
Price and risk
How does the stock behave?
Statements
Every number